Navigation Links
Wall's To Develop Low-fat Ice-cream Using Fish Blood

Wall's have announced their plans to use a protein that has been originally isolated from fish blood to produce the world's first ice creams using genetically// modified technology.

The parent company, Unilever, have claimed that the technique will allow it them to develop ice creams that are of low-calorie, and low fat. They explained that they could be using this technology to make newer versions of their best selling products like the Cornetto, Magnum, and Carte D'Or.

There are debates going on about the GM technology due to an increased desire by consumers for a more natural 'real' food diet, where in artificial additives are removed. But officials at the Unilever believe the benefits of low-fat ice cream could prevail over any doubts about GM.

It was explained that the blood protein is originally extracted from an eel-like ocean pout fish, which uses the protein to survive extreme cold at the bottom of the seas. They stated that the protein has been chemically synthesised and it can be grown in vast vases that can produce a brownish liquid. This liquid, they explained could lower the lowers the temperatures at which ice crystals form and the shape they take up. They claimed that they could then create a stiff and solid mixture by using less cream or fat.

The company has also announced that they have submitted an application with the Food Standard Agency to use the new technology, involving the GM process. Unilever officials have also stated that the process has already been approved in the U.S. and in other parts of the world. They categorically stated that no GM material would remains in the final product, and that the process involving the GM element would be used to only create the protein.

Clare Oxborrow a food campaigner of the Friends of the Earth has said: 'At a time when more and more consumers want to choose unadulterated food, it's disappointing to see Unilever investing in this unnecessa ry development in overly processed food.'


'"/>




Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Risk Of Developing Arthritis
4. Developing HIV fighter
5. Missing Protein In Cancer Development
6. Tomatoes Might Inhibit the Development Of Prostate Cancer
7. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
8. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
9. Men Who at Risk Of Developing Prostate Cancer
10. Identifying The Risks Of Developing Schizophrenia
11. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: